EMD Serono

BAVENCIO

Manufacturer:

EMD Serono

Bavencio HCPCS:

J9023

HCPCS Code Descriptor:

Injection, avelumab, 10 mg

Category:

J Code

Bavencio NDCs:

44087-3535-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Bavencio:

BAVENCIO is an Oncology drug manufactured by EMD Serono and administered via the Intravenous route of administration. The J Code: J9023 is aligned to the drug BAVENCIO.

ACCESS PRICING AND MORE BY REGISTERING

J9023 Added Date:

January 1, 2018

J9023 Effective Date:

January 1, 2018

J9023 Termination Date:

HCPCS Active

Bavencio billing and coding information can be found through Emd Serono at the link below:
Bavencio patient assistance information can be found through CoverOne at the URL: https://www.coverone.com/en/home.html
BAVENCIO prescribing information can be found at the link below:
Information regarding BAVENCIO’s side effects can be found at MedlinePlus